Nevertheless, TPC still retain several BC features, as indicated by the up-regulation of genes such as CD22 (S4 Table), plus a trend towards elevated transcript levels of MS4A1 (CD20) (S1 Table), an observation corroborated at the protein level [13]. This evidence concerns the gene CD22 and breast cancer.